Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Light-triggered Ultra-precise Carbon-enhanced phycocyanin Engineered Needles for Therapy

Project description

3D-printed microneedle patch for skin cancer therapy

Photodynamic therapy (PDT) anchors the fight against non-melanoma lesions, Europe’s most prevalent form of cancer. However, three major drawbacks compromise its potential. Poor targeting precision, lack of feedback loops, and an absolute dependence on oxygen drastically reduce the treatment’s real-world impact and keep it out of reach for many patients. Supported by the Marie Skłodowska-Curie Actions programme, the LUCENT project is developing a 3D-printed microneedle patch for light-activated cancer therapy. This patch combines phycocyanin, a natural dye that produces reactive oxygen species and offers optical feedback, with biocompatible carbon nanodots that generate mild heat to enhance treatment in low-oxygen areas. Activated by low-power red light, this patch is expected to provide localised, self-regulated therapy suitable for outpatient or home use.

Objective

Skin cancer is the most common malignancy in Europe, and its incidence is rising due to UV exposure and ageing populations. While photodynamic therapy (PDT) is already used to treat non-melanoma lesions, current methods suffer from poor spatial precision, lack of feedback control, and dependence on oxygen. These limitations reduce efficacy and make treatment uncomfortable or inaccessible for many patients. In LUCENT, I aim to develop a smart, 3D-printed microneedle patch for light-activated cancer therapy. The device will combine two light-responsive materials: a natural dye (phycocyanin) that produces reactive oxygen species and provides optical feedback, with biocompatible carbon nanodots that generate mild heat to boost treatment in oxygen-poor areas. Together, they allow localised, self-regulated therapy activated by low-power red light, suitable for outpatient or home use. My project brings together photochemistry, nanomaterial design, and 3D biomedical fabrication within a unified therapeutic system. I will combine experimental and theoretical tools to study material behaviour under light, optimise performance, and validate the patch in skin-relevant models. My background in photophysics, carbon nanodots, and polymer-based optical devices prepares me to lead this challenge. The host institution offers world-class expertise in bio-based materials and a strong track record in interdisciplinary innovation. A secondment in 3D printing will support the translational path of the project. LUCENT will help me shift from fundamental research to applied therapy, establish my independence in light-responsive materials, and contribute to decentralised cancer care in Europe.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

UNIVERZITA PALACKEHO V OLOMOUCI
Net EU contribution
€ 191 918,16
Address
KRIZKOVSKEHO 8
771 47 Olomouc
Czechia
Region
Česko Střední Morava Olomoucký kraj
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)